Follow
A1M Pharma AB
Nasdaq First North Sweden (Sweden)
A1M Pharma AB is engaged in the research, development, and commercialization of medical treatment and diagnosis based on the protein alpha-1-microglobulin. The company produces an intravenous drug for the treatment of preeclampsia and for diagnostic testing.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
Media
Exercise
Price
1.00 SEK
Exercise period(s)
07 Oct - 25 Oct 2019
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
A1M
SE0009973357
Nasdaq First North Sweden
Sweden (SE)
Details of share in A1M Pharma AB with ticker A1M
Status
Active
Order book id
Amount of instruments
129 667 745
Par value
0.4000
Market cap
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Listing
-
-
03 Apr 2013
Direct listing of A1M Pharma AB on Spotlight
Former ISIN
SE0005876828
Market
Spotlight
Status
Listed
Type
Price
Pre-money valuation
Time
New issue
2.60 SEK
40M SEK
13 May - 27 May 2014
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
13 May - 27 May 2014
Subscription price
Price per share
2.60 SEK
Target to raise
23 980 000 SEK
Types
Share issue
Pre-money valuation
40 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:5. For each existing share one (1) subscription right is obtained. The holding of five (5) subscription rights entitles the holder to subscribe for three (3) new shares.
Type
Price
Pre-money valuation
Time
New issue
5.50 SEK
159.4M SEK
15 Apr - 29 Apr 2015
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
15 Apr - 29 Apr 2015
Subscription price
11.00 SEK
Price per share
5.50 SEK
Target to raise
29 000 000 SEK
Types
Share issue
Pre-money valuation
159 400 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. One (1) unit right is obtained for each existing share. Holding of eleven (11) unit rights entitles the holder to subscribe for one (1) unit. One (1) unit consists of two (2) new shares and one (1) free-of-charge warrants of series TO 1.
Type
Price
Pre-money valuation
Time
Exercise
6.00 SEK
-
05 Nov - 24 Nov 2015
Option exercise terms for A1M TO 1
Market
Spotlight
Exercise period(s)
05 Nov - 24 Nov 2015
Exercise price
6.00 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
New issue
2.60 SEK
98.3M SEK
19 May - 02 Jun 2016
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
19 May - 02 Jun 2016
Subscription price
Price per share
2.60 SEK
Target to raise
43 700 000 SEK
Types
Share issue
Pre-money valuation
98 300 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:9. For each existing share one (1) subscription right is obtained. The holding of nine (9) subscription rights entitles the holder to subscribe for four (4) new shares.
Type
Price
Pre-money valuation
Time
New issue
0.75 SEK
41M SEK
24 Mar - 07 Apr 2017
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
24 Mar - 07 Apr 2017
Subscription price
2.25 SEK
Price per share
0.75 SEK
Target to raise
122 900 000 SEK
Types
Share issue
Pre-money valuation
41 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:1. One (1) unit right is obtained for each existing share. One (1) such unit right entitles the holder to subscribe for one (1) Unit consisting of three (3) new shares and one (1) warrant entitling to subscribe for one (1) new share in the company.
Type
Price
Pre-money valuation
Time
Market move
-
-
20 Jun 2017
Listing of A1M Pharma AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
A1M Pharma AB changed it’s listing from Spotlight to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North was the 20th of June 2017
Type
Price
Pre-money valuation
Time
Exercise
15.00 SEK
-
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Option exercise terms for A1M TO 2
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Exercise price
15.00 SEK
Status
Closed
Issue terms
Twenty (20) equity rights give the right to subcribe for one (1) new share in A1M Pharma AB.
Type
Price
Pre-money valuation
Time
New issue
5.00 SEK
41.5M SEK
07 Mar - 21 Mar 2018
Share issue in A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
07 Mar - 21 Mar 2018
Subscription price
Price per share
5.00 SEK
Target to raise
83 000 000 SEK
Types
Share issue
Pre-money valuation
41 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:1. For each existing share one (1) subscription right is obtained. Such a subscription right entitles the holder to subscribe for two (2) new shares in the company.
Type
Price
Pre-money valuation
Time
New issue
0.85 SEK
17.5M SEK
06 Feb - 20 Feb 2019
Share issue in A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
06 Feb - 20 Feb 2019
Subscription price
10.20 SEK
Price per share
0.85 SEK
Target to raise
70 539 000 SEK
Types
Share issue
Pre-money valuation
17 500 000 SEK
Subscription block size
Minimum subscription
Record date
31 Jan 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:1. Each existing share entitles one (1) unit right. Three (3) unit rights give the right to subscribe for one (1) unit. One (1) unit contains twelve (12) new shares and four (4) free warrants.
Type
Price
Pre-money valuation
Time
New issue
1.05 SEK
108.92M SEK
17 Jun 2019
Share issue in A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription date
17 Jun 2019
Subscription price
1.05 SEK
Price per share
1.05 SEK
Target to raise
27 230 226 SEK
Types
Share issue
Pre-money valuation
108 920 906 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue.
Type
Ticker
ISIN
Market
OPTION
A1M TO 3
SE0012230696
Nasdaq First North Sweden
Sweden (SE)
Details of option in A1M Pharma AB with ticker A1M TO 3
Status
Active
Order book id
46AT11
Amount of instruments
27 662 452
Market cap
Currency
SEK
Segment
First North
Trading period
04 Sep 2019 - 23 Oct 2019
Terms
One (1) warrant entitle to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Exercise
1.00 SEK
-
07 Oct - 25 Oct 2019
Option exercise terms for A1M TO 3
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
07 Oct - 25 Oct 2019
Exercise price
1.00 SEK
Status
Active
Issue terms
One (1) warrant entitle to subscribe for one (1) new share.
Type
Ticker
ISIN
Market
OPTION
A1M TO
SE0012230696
Nasdaq First North Sweden
Sweden (SE)
Details of option in A1M Pharma AB with ticker A1M TO
Status
Active
Order book id
Amount of instruments
27 662 452
Market cap
Currency
SEK
Segment
First North
Terms
Type
Ticker
ISIN
Market
SHARE
A1M
SE0009973357
Nasdaq First North Sweden
Sweden (SE)
Details of share in A1M Pharma AB with ticker A1M
Status
Active
Order book id
Amount of instruments
129 667 745
Par value
0.4000
Market cap
Currency
SEK
Segment
First North
Terms
Type
Price
Pre-money valuation
Time
Listing
-
-
03 Apr 2013
Direct listing of A1M Pharma AB on Spotlight
Former ISIN
SE0005876828
Market
Spotlight
Status
Listed
Type
Price
Pre-money valuation
Time
New issue
2.60 SEK
40M SEK
13 May - 27 May 2014
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
13 May - 27 May 2014
Subscription price
Price per share
2.60 SEK
Target to raise
23 980 000 SEK
Types
Share issue
Pre-money valuation
40 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:5. For each existing share one (1) subscription right is obtained. The holding of five (5) subscription rights entitles the holder to subscribe for three (3) new shares.
Type
Price
Pre-money valuation
Time
New issue
5.50 SEK
159.4M SEK
15 Apr - 29 Apr 2015
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
15 Apr - 29 Apr 2015
Subscription price
11.00 SEK
Price per share
5.50 SEK
Target to raise
29 000 000 SEK
Types
Share issue
Pre-money valuation
159 400 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Preferential right 2:11. One (1) unit right is obtained for each existing share. Holding of eleven (11) unit rights entitles the holder to subscribe for one (1) unit. One (1) unit consists of two (2) new shares and one (1) free-of-charge warrants of series TO 1.
Type
Price
Pre-money valuation
Time
New issue
2.60 SEK
98.3M SEK
19 May - 02 Jun 2016
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
19 May - 02 Jun 2016
Subscription price
Price per share
2.60 SEK
Target to raise
43 700 000 SEK
Types
Share issue
Pre-money valuation
98 300 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:9. For each existing share one (1) subscription right is obtained. The holding of nine (9) subscription rights entitles the holder to subscribe for four (4) new shares.
Type
Price
Pre-money valuation
Time
New issue
0.75 SEK
41M SEK
24 Mar - 07 Apr 2017
Share issue in A1M Pharma AB
Former ISIN
SE0005876828
Market
Spotlight
Subscription period
24 Mar - 07 Apr 2017
Subscription price
2.25 SEK
Price per share
0.75 SEK
Target to raise
122 900 000 SEK
Types
Share issue
Pre-money valuation
41 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 3:1. One (1) unit right is obtained for each existing share. One (1) such unit right entitles the holder to subscribe for one (1) Unit consisting of three (3) new shares and one (1) warrant entitling to subscribe for one (1) new share in the company.
Type
Price
Pre-money valuation
Time
Market move
-
-
20 Jun 2017
Listing of A1M Pharma AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
A1M Pharma AB changed it’s listing from Spotlight to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North was the 20th of June 2017
Type
Price
Pre-money valuation
Time
New issue
5.00 SEK
41.5M SEK
07 Mar - 21 Mar 2018
Share issue in A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
07 Mar - 21 Mar 2018
Subscription price
Price per share
5.00 SEK
Target to raise
83 000 000 SEK
Types
Share issue
Pre-money valuation
41 500 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 2:1. For each existing share one (1) subscription right is obtained. Such a subscription right entitles the holder to subscribe for two (2) new shares in the company.
Type
Price
Pre-money valuation
Time
New issue
0.85 SEK
17.5M SEK
06 Feb - 20 Feb 2019
Share issue in A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription period
06 Feb - 20 Feb 2019
Subscription price
10.20 SEK
Price per share
0.85 SEK
Target to raise
70 539 000 SEK
Types
Share issue
Pre-money valuation
17 500 000 SEK
Subscription block size
Minimum subscription
Record date
31 Jan 2019
Offer status
Closed
Listing status
Listed
Issue terms
Pre-emption 4:1. Each existing share entitles one (1) unit right. Three (3) unit rights give the right to subscribe for one (1) unit. One (1) unit contains twelve (12) new shares and four (4) free warrants.
Type
Price
Pre-money valuation
Time
New issue
1.05 SEK
108.92M SEK
17 Jun 2019
Share issue in A1M Pharma AB
Market
Nasdaq First North Sweden
Subscription date
17 Jun 2019
Subscription price
1.05 SEK
Price per share
1.05 SEK
Target to raise
27 230 226 SEK
Types
Share issue
Pre-money valuation
108 920 906 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed share issue.
Type
Ticker
ISIN
Market
OPTION
A1M TO 1
SE0006887790
Spotlight
Sweden (SE)
Details of option in A1M Pharma AB with ticker A1M TO 1
Status
Archived
Order book id
109099
Amount of instruments
Market cap
Currency
SEK
Trading period
09 Jun 2015 - 24 Nov 2015
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Exercise
6.00 SEK
-
05 Nov - 24 Nov 2015
Option exercise terms for A1M TO 1
Market
Spotlight
Exercise period(s)
05 Nov - 24 Nov 2015
Exercise price
6.00 SEK
Status
Closed
Issue terms
One (1) warrant entitles the holder to subscribe for one (1) new share.
Type
Ticker
ISIN
Market
OPTION
A1M TO 2
SE0009773450
Nasdaq First North Sweden
Sweden (SE)
Details of option in A1M Pharma AB with ticker A1M TO 2
Status
Archived
Order book id
137176
Amount of instruments
35 555 556
Market cap
Currency
SEK
Segment
First North
Trading period
20 Jun 2017 - 06 Dec 2017
Terms
Twenty (20) equity rights give the right to subcribe for one (1) new share in A1M Pharma AB.
Type
Price
Pre-money valuation
Time
Exercise
15.00 SEK
-
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Option exercise terms for A1M TO 2
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
28 Aug - 08 Sep 2017
27 Nov - 08 Dec 2017
Exercise price
15.00 SEK
Status
Closed
Issue terms
Twenty (20) equity rights give the right to subcribe for one (1) new share in A1M Pharma AB.
Type
Ticker
ISIN
Market
OPTION
A1M TO 3
SE0012230696
Nasdaq First North Sweden
Sweden (SE)
Details of option in A1M Pharma AB with ticker A1M TO 3
Status
Active
Order book id
46AT11
Amount of instruments
27 662 452
Market cap
Currency
SEK
Segment
First North
Trading period
04 Sep 2019 - 23 Oct 2019
Terms
One (1) warrant entitle to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Exercise
1.00 SEK
-
07 Oct - 25 Oct 2019
Option exercise terms for A1M TO 3
Former ticker
A1M TO
Market
Nasdaq First North Sweden
Exercise period(s)
07 Oct - 25 Oct 2019
Exercise price
1.00 SEK
Status
Active
Issue terms
One (1) warrant entitle to subscribe for one (1) new share.
Type
Ticker
ISIN
Market
OPTION
A1M TO
SE0012230696
Nasdaq First North Sweden
Sweden (SE)
Details of option in A1M Pharma AB with ticker A1M TO
Status
Active
Order book id
Amount of instruments
27 662 452
Market cap
Currency
SEK
Segment
First North
Terms
People
Number of Employees
14 people
Tomas Jörgen Eriksson
CEO
Martin Austin
Chairman of the board
Anders Ermén
Board member
Cristina Glad
Board member
Magnus Gram
Board member
Martin Austin
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY
Website

Address
Scheelevägen 22
Zip code
223 63
City/district
Lund
Country
Sweden (SE)
Registration number
556755-3226
LEI code
549300DTX7T87FGYG180
First trade date
03 Apr 2013
Registration date
10 Apr 2008
Short name
A1M Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More